Enhancing and targeting nucleic acid delivery by magnetic force

  title={Enhancing and targeting nucleic acid delivery by magnetic force},
  author={Christian Plank and Martina Anton and Carsten Rudolph and Joseph Rosenecker and Florian Kr{\"o}tz},
  journal={Expert Opinion on Biological Therapy},
  pages={745 - 758}
Insufficient contact of inherently highly active nucleic acid delivery systems with target cells is a primary reason for their often observed limited efficacy. Physical methods of targeting can overcome this limitation and reduce the risk of undesired side effects due to non-target site delivery. The authors and others have developed a novel means of physical targeting, exploiting magnetic force acting on nucleic acid vectors associated with magnetic particles in order to mediate the rapid… 

Magnetic and acoustically active microbubbles loaded with nucleic acids for gene delivery.

The protocols for preparation of magnetic lipospheres and microbubbles for nucleic acid delivery are described, and the procedures for labeling the components of the bubbles for the visualization of the vectors and their characterization, such as magnetic responsiveness and ultrasound contrast effects are described.

Magnetic targeting for site-specific drug delivery: applications and clinical potential

More efficient targeting magnetic systems in combination with prolonged circulation lifespan and carriers' surface recognition properties will improve the targeting efficiency of magnetic nanocarriers and enhance therapeutic agent availability at the molecular site of agent action.

Nucleic acid delivery using magnetic nanoparticles: the Magnetofection technology.

The principles of the Magnetofection technology and its benefits as compared with standard transfection methods are discussed and future trends in the development of new magnetic nanoparticle formulations will be outlined.

Advances in Magnetofection Magnetically Guided Nucleic Acid Delivery: a Review

During the last decade, nanomagnetic methods for delivering and targeting nucleic acids have been developed which are often referred to as magnetofection. Nucleic acids carry the building plans of

Generation of magnetic nonviral gene transfer agents and magnetofection in vitro

This protocol can be used for cells that are difficult to transfect, such as primary cells, and may also be applied to viral nucleic acid delivery, and will be useful for screening vector compositions and novel magnetic nanoparticle preparations for optimized transfection efficiency in any cell type.

Magnetic and Acoustically Active Lipospheres for Magnetically Targeted Nucleic Acid Delivery

A synergistic effect of magnetic field and ultrasound is observed in site‐specific plasmid deposition in a dorsal skinfold chamber model in mice after injection into the carotis and in functional plasmids delivery to the vasculature after intrajugular injection.

Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro.

This chapter describes how to design and conduct experiments to deliver siRNA to adherent cell cultures in vitro by magnetic force-assisted transfection using self-assembled complexes of small

Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field

The highly efficient gene transfer already within 5 min shows that this technique is a powerful tool for future in vivo studies, where rapid gene delivery is required before systemic clearance or filtration of the gene vectors occurs.

Localized nucleic acid delivery to living cells using nanobiotechnology approaches

This work localizes nucleic acid delivery exploiting carrier materials, on the one hand implantable biomaterials doted with vectors for tissue engineering purposes, and magnetic nanoparticles associated with vectors which can be magnetically directed to a target site.



Magnetofection: Enhancing and Targeting Gene Delivery with Superparamagnetic Nanoparticles and Magnetic Fields

The attractive forces of magnetic gradient fields on superparamagnetic nanoparticles are exploited to potentiate the efficacies, improve the kinetics and dose response, and hence the efficacy of the gene transfer process is improved.

Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo

Low efficiencies of nonviral gene vectors, the receptor-dependent host tropism of adenoviral or low titers of retroviral vectors limit their utility in gene therapy. To overcome these deficiencies,

Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery

Novel copolymers of poly(ethylene glycol) and reactive linkers which are derivatized with anionic peptides after copolymerization are designed and applied to coat positively charged nonviral gene vectors by electrostatic interactions.

Magnetofection--a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo.

Preclinical experiences with magnetic drug targeting: tolerance and efficacy.

A magnetic fluid to which drugs, cytokines, and other molecules can be chemically bound to enable those agents to be directed within an organism by high-energy magnetic fields is developed.

The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery

Abstract In order to enhance and target gene delivery we have previously established a novel method, termed magnetofection, which uses magnetic force acting on gene vectors that are associated with

Theory and in vivo application of electroporative gene delivery.

An overview of the theory and practice of electroporative gene transfer is provided to aid researchers that wish to employ the method for preclinical and translational gene therapy, NAV, and functional genomic research.

Magnetic microcapsules for targeted delivery of anticancer drugs.

Results indicate the feasibility and effectiveness of the magnetic microcapsules as a targeted drug delivery system and show that VX2 tumors in the rabbit hind limb and urinary bladder were successfully treated with magnetic control of FM-MMC-mc.

Magnetically controlled targeted micro-carrier systems.


Having a higher magnetic susceptibility and saturation than particles made of iron oxides, the iron containing MTCs are captured by the external magnetic field more efficiently and at depths up to 14 cm, a clinically relevant depth for most solid tumors.